Galidesivir (BCX 4430) |
| Catalog No.GC32092 |
Le galidesivir (BCX 4430) (BCX4430), un analogue de l'adénosine et un agent antiviral À action directe, perturbe l'activité de l'ARN polymérase virale dépendante de l'ARN (RdRp).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 249503-25-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Galidesivir (BCX 4430) is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile.
Review for Galidesivir (BCX 4430)
Average Rating: 5 (Based on Reviews and 22 reference(s) in Google Scholar.)
Review for Galidesivir (BCX 4430)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *